Tactile Systems Technology (TCMD) Aandeel Koers

Tactile Systems Technology Inc is primarily active in the healthcare industry.

The main competitors of Tactile Systems Technology Inc in the market include companies such as Medtronic, Smith & Nephew, Hill-Rom Holdings, and Acelity.

Tactile Systems Technology Inc, commonly known as Tactile Medical, is a leading medical technology company based in Minneapolis, Minnesota. Founded in 1995, the company specializes in developing and providing at-home therapy devices and solutions for the treatment of lymphedema and chronic venous insufficiency. Tactile Medical's mission is to advance patient care by addressing unmet medical needs through innovative products and services. With its cutting-edge technology and dedication to improving patients' quality of life, Tactile Medical has become a trusted name in the medical community. Despite its relatively young age, the company has achieved significant growth and recognition, making it a promising investment option for those interested in the medical technology sector.

Tactile Systems Technology Inc has achieved several significant milestones. One notable accomplishment is its successful initial public offering in July 2016, which enabled the company to raise funds for future growth and expansion. Additionally, Tactile Systems has developed and launched innovative medical devices, including its Flexitouch system for lymphedema management. The company has received multiple awards and recognition for its contributions to the healthcare industry, such as being named to the Forbes 2017 list of America's Best Small Companies. Tactile Systems Technology Inc continues to focus on advancing patient care through its advanced medical solutions and dedication to innovation.

Tactile Systems Technology Inc is primarily present in the United States.

Tactile Systems Technology Inc is a leading medical technology company that specializes in developing and providing at-home therapy solutions. Their core values include patient-centricity, innovation, integrity, and collaboration. With a focus on improving the lives of patients with chronic diseases, Tactile Systems Technology Inc is dedicated to developing high-quality products that offer comfort and convenience. The company's corporate philosophy revolves around delivering effective and personalized healthcare solutions through a comprehensive understanding of patient needs. Tactile Systems Technology Inc consistently prioritizes patient well-being and strives to enhance their quality of life through continuous advancements in medical technology and patient care.

Analisten hanteren momenteel een gemiddeld koersdoel van 40,00 USD voor het aandeel Tactile Systems Technology (mediaan: 40,00 USD), oftewel +46,7 % ten opzichte van de laatste koers. De consensus is gebaseerd op 10 analistenratings.

Tactile Systems Technology Koersdoelstellingen analisten 2026

10 analisten beoordelen het aandeel Tactile Systems Technology momenteel: 9 adviseren kopen, 1 houden en 0 verkopen. Voor 2026 verwachten analisten dat Tactile Systems Technology een omzet van 362,14 Miljoen USD en winst per aandeel van 1,09 USD behaalt.

Tactile Systems Technology Koersdoelstellingen analisten 2026

Omgezet tegen de huidige wisselkoers noteert het aandeel Tactile Systems Technology op 24,63 EUR (27,26 USD).

Het aandeel Tactile Systems Technology (TCMD) is genoteerd aan 3 beurzen, waaronder: NASDAQ (TCMD), Frankfurt (3L3.F), München (3L3.MU).

The company Tactile Systems Technology Inc is a US-American company based in Minneapolis that specializes in the development and distribution of medical devices for the treatment of peripheral circulation disorders. The company's business model is based on a wide range of non-invasive therapy devices that are used by patients to treat circulation disorders in the lower extremities. The Tactile product portfolio includes a range of devices, from light compression stockings to advanced systems with more comprehensive functions and applications. Tactile devices have been designed to improve circulation and support the healing of chronic wounds or injuries caused by poor circulation. The therapy devices are based on a patented technological approach - a unique pneumatic system that applies pulsating pressure to the lower extremities to improve circulation and reduce edema. The devices are designed to meet a variety of patient needs and can be used both in a clinical setting and at home. In addition to its therapy devices, Tactile also offers a range of services to support patients in the effective use of the devices and improve outcomes. These include patient and medical professional training programs, support services, and data analysis tools to ensure optimal therapy. The market for peripheral circulation disorders and chronic wounds is large and growing. According to estimates from the American Heart Association, more than 8.5 million people in the United States alone suffer from circulation disorders in the lower extremities, and this number is expected to continue rising due to factors such as increasing age and lifestyle diseases like diabetes. Tactile has managed to establish itself as a market leader in this segment by providing innovative products and services tailored to the needs of patients and medical professionals. The company has built a strong brand and made its products popular among doctors and clinics in the US. It also has a strong presence in the international market and has successfully expanded into new regions. Overall, Tactile offers its customers an integrated system of therapy devices and services aimed at improving the treatment of circulation disorders and maximizing patient outcomes. With its proven business model, strong brand presence, and commitment to product innovation and quality, Tactile is well positioned to continue growing successfully and increase its market share.

De verwachte omzet van Tactile Systems Technology bedraagt 362,14 Miljoen USD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.

De verwachte winst van Tactile Systems Technology bedraagt 25,10 Miljoen USD. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.

De koers-winstverhouding (P/E) van Tactile Systems Technology bedraagt momenteel 25,04. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het Tactile Systems Technology-aandeel in te schatten.

De koers-omzetverhouding (P/S) van Tactile Systems Technology bedraagt momenteel 1,73. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het Tactile Systems Technology-aandeel.

De Eulerpool Kwaliteitsscore voor Tactile Systems Technology is 5/10.

De ISIN van Tactile Systems Technology is US87357P1003. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.

De WKN van Tactile Systems Technology is A2APEV. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.

Het tickersymbool van Tactile Systems Technology is TCMD. Onder dit beurstickersymbool wordt het Tactile Systems Technology-aandeel op de beurs verhandeld.